These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 33294740)
1. SCUBE1 Controls BMPR2-Relevant Pulmonary Endothelial Function: Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension. Sun W; Tang Y; Tai YY; Handen A; Zhao J; Speyer G; Al Aaraj Y; Watson A; Romanelli ME; Sembrat J; Rojas M; Simon MA; Zhang Y; Lee J; Xiong Z; Dutta P; Vasamsetti SB; McNamara D; McVerry B; McTiernan CF; Sciurba FC; Kim S; Smith KA; Mazurek JA; Han Y; Vaidya A; Nouraie SM; Kelly NJ; Chan SY JACC Basic Transl Sci; 2020 Nov; 5(11):1073-1092. PubMed ID: 33294740 [TBL] [Abstract][Full Text] [Related]
2. The Role of Bone Morphogenetic Protein Receptor Type 2 ( Devendran A; Kar S; Bailey R; Trivieri MG Cells; 2022 Nov; 11(23):. PubMed ID: 36497082 [TBL] [Abstract][Full Text] [Related]
3. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension. Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577 [TBL] [Abstract][Full Text] [Related]
4. Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan. Liang KW; Chang SK; Chen YW; Lin WW; Tsai WJ; Wang KY Front Cardiovasc Med; 2022; 9():911649. PubMed ID: 35811711 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the Methylation and Expression Levels of the BMPR2 Gene by SIN3a as a Novel Therapeutic Mechanism in Pulmonary Arterial Hypertension. Bisserier M; Mathiyalagan P; Zhang S; Elmastour F; Dorfmüller P; Humbert M; David G; Tarzami S; Weber T; Perros F; Sassi Y; Sahoo S; Hadri L Circulation; 2021 Jul; 144(1):52-73. PubMed ID: 34078089 [TBL] [Abstract][Full Text] [Related]
6. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension. Hwangbo C; Lee HW; Kang H; Ju H; Wiley DS; Papangeli I; Han J; Kim JD; Dunworth WP; Hu X; Lee S; El-Hely O; Sofer A; Pak B; Peterson L; Comhair S; Hwang EM; Park JY; Thomas JL; Bautch VL; Erzurum SC; Chun HJ; Jin SW Circulation; 2017 Jun; 135(23):2288-2298. PubMed ID: 28356442 [TBL] [Abstract][Full Text] [Related]
7. MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension. Wang C; Xing Y; Zhang J; He M; Dong J; Chen S; Wu H; Huang HY; Chou CH; Bai L; He F; She J; Su A; Wang Y; Thistlethwaite PA; Huang HD; Yuan JX; Yuan ZY; Shyy JY Circ Res; 2022 Oct; 131(10):828-841. PubMed ID: 36252121 [TBL] [Abstract][Full Text] [Related]
8. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation. Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556 [TBL] [Abstract][Full Text] [Related]
10. Combination Therapy with STAT3 Inhibitor Enhances SERCA2a-Induced BMPR2 Expression and Inhibits Pulmonary Arterial Hypertension. Bisserier M; Katz MG; Bueno-Beti C; Brojakowska A; Zhang S; Gubara S; Kohlbrenner E; Fazal S; Fargnoli A; Dorfmuller P; Humbert M; Hata A; Goukassian DA; Sassi Y; Hadri L Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502015 [TBL] [Abstract][Full Text] [Related]
11. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension. Hong KH; Lee YJ; Lee E; Park SO; Han C; Beppu H; Li E; Raizada MK; Bloch KD; Oh SP Circulation; 2008 Aug; 118(7):722-30. PubMed ID: 18663089 [TBL] [Abstract][Full Text] [Related]
12. In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug. Hopper RK; Moonen JR; Diebold I; Cao A; Rhodes CJ; Tojais NF; Hennigs JK; Gu M; Wang L; Rabinovitch M Circulation; 2016 May; 133(18):1783-94. PubMed ID: 27045138 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension. McMurtry MS; Moudgil R; Hashimoto K; Bonnet S; Michelakis ED; Archer SL Am J Physiol Lung Cell Mol Physiol; 2007 Apr; 292(4):L872-8. PubMed ID: 17142350 [TBL] [Abstract][Full Text] [Related]
14. SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension. Han C; Hong KH; Kim YH; Kim MJ; Song C; Kim MJ; Kim SJ; Raizada MK; Oh SP Hypertension; 2013 May; 61(5):1044-52. PubMed ID: 23478097 [TBL] [Abstract][Full Text] [Related]
17. Single-cell RNA sequencing reveals that Du M; Jiang H; Liu H; Zhao X; Zhou Y; Zhou F; Piao C; Xu G; Ma F; Wang J; Perros F; Morrell NW; Gu H; Yang J Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34857612 [TBL] [Abstract][Full Text] [Related]
18. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension. Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082 [TBL] [Abstract][Full Text] [Related]
19. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation. Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075 [TBL] [Abstract][Full Text] [Related]